Amarin Calls For ITC Investigation Of Omega-3 Supplements
Amarin Pharma Inc. asked the U.S. International Trade Commission on Wednesday to investigate more than a dozen drug producers worldwide that it accused of falsely labeling their allegedly unapproved new drugs...To view the full article, register now.
Already a subscriber? Click here to view full article